Secures Drug License to launch new product Flupentixol Hydrochloride
Gennex Laboratories announced that it has been awarded by the Drugs Control Administration, Government of Telangana, Certificate for good manufacturing practices in the manufacturing and quality control operations as recommended by the World Health Organization, for a period of 2 years.This certificate has been awarded after inspection of the Company's manufacturing facility by the Joint Inspection Team of officers from Central Drugs Standard Control Organization and Drugs Control Administration, Telangana with regard to the Company's adherence to manufacturing and quality control norms of World Health Organization. This Award, the Company believes, will provide a cutting-edge to penetrate European market in future.
The Company has also received Consent For Operations (CFO) from the Telangana State Pollution Control Board (TSPCB) for a further period of 5 years after a team of officers who inspected the Company's manufacturing and effluent treatment facilities recorded its satisfaction. The Company, however, continues to make efforts to ensure that the Pollution Control norms are strictly adhered to and necessary measures taken from time to time.
The Drugs Control Administration, Telangana had, on 06 May 2017, approved the Company's new product namely Flupentixol Hydrochloride and issued the Drug Licence for the same. The new product is an anti-depressant drug that goes in combination with Melitracin hydrochloride and is widely in demand notably in countries like Bangladesh
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
